14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19.
SMC has now published a Collaborative Advice Document and recommendations are aligned with the NICE guidance.
Read SMC News